In 2018，Launched RSA isothermal amplification molecular diagnostic technology system and supporting reagents.

In 2019，Passed ISO13485 and ISO9001 international certification and Launched membrane adsorption method nucleic acid extraction reagent.

In 2020，Successfully applied for Science and Technology Innovation Commission's research project and Launched magnetic bead extraction reagent, self-developed nucleic acid extractor and COVID-19 PCR detection kit and exported to more than 50 countries and regions.

In 2021，Approved as a national high-tech enterprise.

In 2022，The new manufacturing site has been completed and Launched variable tests for the respiratory tract, bloodborne pathogens, sexually transmitted diseases, and prenatal and postnatal care, rapidly expanding product applications.

In 2023, Singuway actively participated in exhibitions worldwide, expanding into markets in the Middle East, Russia, Europe, and Asia. We successfully developed a unique room temperature crystallization drying technology, addressing the challenge of PCR reagent transportation. Additionally, our PCR mobile laboratory project met the demand for instant testing, and we deepened our involvement in the fields of sexually transmitted diseases and respiratory multi-panel testing, developing more comprehensive products. These efforts contributed significantly to the global healthcare industry.